RCM Technologies vs Star Equity
RCMT and STRR side by side, both in personnel supply services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RCMT and STRR compare
RCM Technologies is the larger company, worth 6.5 times as much as Star Equity ($226M against $34.5M).
Star Equity grew revenue faster over the last twelve months (52.1% versus 11.2% for RCM Technologies).
RCM Technologies keeps more of each dollar of sales as profit, with a net margin of 5.1% compared with −4.3% at Star Equity.
RCM Technologies scores higher on the StockData Score (13 against 6 for Star Equity), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RCMT | STRR |
|---|---|---|
| Size and price | ||
| Market cap | $226M | $34.5M |
| Share price | $31.73 | $9.34 |
| Change, 1 year | 67.9% | −7.3% |
| Change, 5 years | 331% | −68.1% |
| Beta (5Y) | 1.45 | 0.81 |
| Employees | 250 | 1,200 |
| StockData Score | ||
| Total score | 13 (better) | 6 |
| Valuation score | 2 | 3 (better) |
| Growth score | 1 | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 6 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 13.7× | – |
| P/S | 0.7× | 0.2× (better) |
| P/B | 4.6× | 0.6× (better) |
| EV/EBITDA | 7.8× | – |
| P/FCF | 9.9× | – |
| PEG | 6.02 | – |
| FCF yield | 10.1% (better) | −41.1% |
| Fair value | $32.48 | $21.88 |
| Margin of safety | 2.3% | 57.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 11.2% | 52.1% (better) |
| Revenue growth, 5Y average | 16.3% (better) | 11.2% |
| Net income growth (TTM) | 25.9% | – |
| EPS growth (TTM) | 31.3% | – |
| Profitability | ||
| Gross margin | 26.9% | 42.0% (better) |
| Operating margin | 7.7% (better) | −3.4% |
| Net margin | 5.1% (better) | −4.3% |
| FCF margin | 6.8% (better) | −6.8% |
| Return on equity | 39.5% (better) | −18.2% |
| Return on invested capital | 51.2% (better) | −13.3% |
| Financial health | ||
| Debt / equity | 0.00 | 0.15 (better) |
| Current ratio | 1.92 | 1.96 (better) |
| Altman Z-score | 5.35 (better) | −3.25 |
| Piotroski F-score | 8 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | 3.9% | 10.2% (better) |
| Shareholder yield | 3.9% | 10.2% (better) |
| Ownership | ||
| Held by institutions | 41.1% | 25.9% |
| Held by insiders | 33.3% | 40.9% |
| Insider net buying, 12 months | −$12.6M | $671K (better) |
| Short interest, % of float | 5.0% | – |
Go deeper
- RCMT stock overview
- RCMT income statement
- RCMT valuation and score
- STRR stock overview
- STRR income statement
- STRR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.